Abstract: A process for the preparation of 4-[2-(Di-n-propylamino)ethyl]-2,3-dihydro-1H-indol-2-one of formula (I) and its pharmaceutically acceptable salts, solvates, involving new intermediates of compound of formula (A)and(B) wherein R represents (i)a halogen atom selected from fluorine, chlorine atom, bromine atom and iodine atom;(ii)lower alkanesulfonyloxy group selected from methanesulfonyloxy, ethanesulfonylixy, isopropanesulfonyloxy, propanesulfonyloxy, butanesulfonyloxy, tert-butanesulfonyloxy, pentanesulfonyloxy, hexanesulfonyloxy; (iii)substituted or unsubstantiated arylsulfonyloxy group selected from phenylsulfonyloxy, 4-methylphenylsulfonyloxy, 2-methylphenylsulfonyloxy, 4-nitrophenylsulfonyloxy, 4-methoxyphenylsulfonyloxy, 3-chlorophenylsulfonyloxy; (iv)arylalkylsulfonyloxy group selected from benzylsulfonyloxy, 2-phenylethylsulfonyloxy, 4-phenylbutylsulfonyloxy, 4-methylbenzylsulfonyloxy, 2-methylbenzylsulfonyloxy, 4-nitrobenzylsulfonyloxy, 4-methoxybenzylsulfonyloxy, 3-chlorobenzylsulfonyloxy.
| # | Name | Date |
|---|---|---|
| 1 | 77-MUM-2005-SPECIFICATION(MARKED COPY)-(28-12-2011).pdf | 2011-12-28 |
| 2 | 77-MUM-2005-SPECIFICATION(MARKED COPY)- (28-12-2011).pdf | 2011-12-28 |
| 3 | 77-MUM-2005-SPECIFICATION(AMENDED)-(28-12-2011).pdf | 2011-12-28 |
| 4 | 77-MUM-2005-SPECIFICATION(AMENDED)- (28-12-2011).pdf | 2011-12-28 |
| 5 | 77-MUM-2005-CORRESPONDENCE(28-12-2011).pdf | 2011-12-28 |
| 6 | 77-MUM-2005-CLAIMS(AMENDED)-(28-12-2011).pdf | 2011-12-28 |
| 7 | 77-MUM-2005-CLAIMS(AMENDED)- (28-12-2011).pdf | 2011-12-28 |
| 8 | 77-MUM-2005_EXAMREPORT.pdf | 2018-08-09 |
| 9 | 77-MUM-2005-US DOCUMENT(25-7-2011).pdf | 2018-08-09 |
| 10 | 77-MUM-2005-REPLY TO EXAMINATION REPORT(25-7-2011).pdf | 2018-08-09 |
| 11 | 77-mum-2005-power of attorney(23-2-2005).pdf | 2018-08-09 |
| 12 | 77-MUM-2005-OTHER DOCUMENT(13-8-2009).pdf | 2018-08-09 |
| 13 | 77-mum-2005-form 9(23-2-2005).pdf | 2018-08-09 |
| 14 | 77-mum-2005-form 5(23-2-2005).pdf | 2018-08-09 |
| 15 | 77-mum-2005-form 3(23-2-2005).pdf | 2018-08-09 |
| 16 | 77-mum-2005-form 2(title page)-(25-1-2005).pdf | 2018-08-09 |
| 17 | 77-mum-2005-form 2(25-1-2005).pdf | 2018-08-09 |
| 18 | 77-MUM-2005-FORM 18(2-2-2009).pdf | 2018-08-09 |
| 19 | 77-mum-2005-form 1(25-1-2005).pdf | 2018-08-09 |
| 20 | 77-mum-2005-form 1(23-2-2005).pdf | 2018-08-09 |
| 21 | 77-mum-2005-description(complete)-(25-1-2005).pdf | 2018-08-09 |
| 22 | 77-MUM-2005-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(8-9-2015).pdf | 2018-08-09 |
| 23 | 77-MUM-2005-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(30-6-2015).pdf | 2018-08-09 |
| 24 | 77-MUM-2005-CORRESPONDENCE(IPO)-(FER)-(30-1-2012).pdf | 2018-08-09 |
| 25 | 77-MUM-2005-CORRESPONDENCE(IPO)-(FER)-(14-7-2011).pdf | 2018-08-09 |
| 26 | 77-MUM-2005-CORRESPONDENCE(IPO)-(DECISION)-(26-8-2015).pdf | 2018-08-09 |
| 27 | 77-mum-2005-correspondence(ipo)-(19-4-2006).pdf | 2018-08-09 |
| 28 | 77-MUM-2005-CORRESPONDENCE(8-1-2010).pdf | 2018-08-09 |
| 29 | 77-MUM-2005-CORRESPONDENCE(6-8-2009).pdf | 2018-08-09 |
| 30 | 77-MUM-2005-CORRESPONDENCE(4-6-2010).pdf | 2018-08-09 |
| 31 | 77-MUM-2005-CORRESPONDENCE(29-1-2009).pdf | 2018-08-09 |
| 32 | 77-MUM-2005-CORRESPONDENCE(28-6-2012).pdf | 2018-08-09 |
| 33 | 77-MUM-2005-CORRESPONDENCE(2-12-2009).pdf | 2018-08-09 |
| 34 | 77-mum-2005-correspondence(14-6-2008).pdf | 2018-08-09 |
| 35 | 77-MUM-2005-CORRESPONDENCE(13-8-2009).pdf | 2018-08-09 |
| 36 | 77-MUM-2005-CORRESPONDENCE(11-6-2012).pdf | 2018-08-09 |
| 37 | 77-MUM-2005-CLAIMS(AMENDED)-(11-6-2012).pdf | 2018-08-09 |
| 38 | 77-mum-2005-claims(25-1-2005).pdf | 2018-08-09 |
| 39 | 77-MUM-2005-ANNUXER FORM 3(8-1-2010).pdf | 2018-08-09 |
| 40 | 77-MUM-2005-ANNEXURE TO FORM 3(25-7-2011).pdf | 2018-08-09 |
| 41 | 77-MUM-2005-ANNEXURE TO FORM 3(11-6-2012).pdf | 2018-08-09 |
| 42 | 77-mum-2005-abstrct(25-1-2005).pdf | 2018-08-09 |